Used as an intermediate in pharmaceutical synthesis, particularly in the production of active pharmaceutical ingredients (APIs) where chiral pyrrolidine structures are required. Its protected amine group allows for selective reactions in multi-step organic syntheses. Commonly employed in the development of protease inhibitors and central nervous system agents due to the structural stability and stereochemical control it provides. Also utilized in agrochemical research for designing bioactive molecules with improved metabolic resistance.